ATE247966T1 - Behandlung von motorischen fehlfunktionen - Google Patents

Behandlung von motorischen fehlfunktionen

Info

Publication number
ATE247966T1
ATE247966T1 AT96302711T AT96302711T ATE247966T1 AT E247966 T1 ATE247966 T1 AT E247966T1 AT 96302711 T AT96302711 T AT 96302711T AT 96302711 T AT96302711 T AT 96302711T AT E247966 T1 ATE247966 T1 AT E247966T1
Authority
AT
Austria
Prior art keywords
treatment
motor malfunctions
methyl
malfunctions
motor
Prior art date
Application number
AT96302711T
Other languages
English (en)
Inventor
Charles Merrit Beasley Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE247966T1 publication Critical patent/ATE247966T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
AT96302711T 1995-04-21 1996-04-18 Behandlung von motorischen fehlfunktionen ATE247966T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/422,177 US5776928A (en) 1995-04-21 1995-04-21 Method for treating dyskinesias with olanzapine

Publications (1)

Publication Number Publication Date
ATE247966T1 true ATE247966T1 (de) 2003-09-15

Family

ID=23673720

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96302711T ATE247966T1 (de) 1995-04-21 1996-04-18 Behandlung von motorischen fehlfunktionen

Country Status (11)

Country Link
US (1) US5776928A (de)
EP (1) EP0738514B1 (de)
JP (1) JPH11504014A (de)
AT (1) ATE247966T1 (de)
AU (1) AU5555596A (de)
CA (1) CA2218062A1 (de)
DE (1) DE69629618T2 (de)
ES (1) ES2206544T3 (de)
IL (1) IL117971A (de)
WO (1) WO1996032948A1 (de)
ZA (1) ZA963098B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0852496A4 (de) * 1995-09-29 1998-11-11 Lilly Co Eli Verfahren zur behandlung des ticks
TR200000812T2 (tr) * 1997-09-30 2001-07-23 Eli Lilly And Company 2-metil-tieno- benzodiazepin formülasyonu.
US6617321B2 (en) 1997-09-30 2003-09-09 Eli Lilly And Company 2-methyl-thieno-benzodiazepine formulation
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20050153954A1 (en) * 2002-04-23 2005-07-14 Reguri Buchi R. Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
SI21270A (sl) * 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
PT1838716E (pt) * 2005-01-05 2011-07-15 Lilly Co Eli Di-hidrato de pamoato de olanzapina
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
AU5555596A (en) 1996-11-07
ES2206544T3 (es) 2004-05-16
JPH11504014A (ja) 1999-04-06
US5776928A (en) 1998-07-07
EP0738514B1 (de) 2003-08-27
IL117971A0 (en) 1996-08-04
WO1996032948A1 (en) 1996-10-24
ZA963098B (en) 1997-10-20
DE69629618T2 (de) 2004-06-17
EP0738514A1 (de) 1996-10-23
DE69629618D1 (de) 2003-10-02
IL117971A (en) 1999-12-31
CA2218062A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
ATE247966T1 (de) Behandlung von motorischen fehlfunktionen
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
DK1438957T3 (da) Raloxifen til behandling af postmenopausal osteoporose
CY2436B1 (en) Medicament for treating cardiac inflammatory disease.
NO961483D0 (no) Fremgangsmåte for behandling av oljeholdig formasjon
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
NO975662D0 (no) Anvendelse av 1,2,4-triazolderivater for fremstilling av et medikament for behandling av cancer
YU42298A (sh) Upotreba olanzapina za pripremanje leka korisnog kod akutnog bola
NO973531L (no) Anvendelse av melatonin for behandling av pasienter som lider av medikamentavhengighet
ZA971600B (en) Treatment of macular edema.
EE03437B1 (et) Benseenamiidid neurodegeneratiivsete haiguste ravimiseks
ZA964198B (en) Treatment regime for skin.
NO974766L (no) Fremgangsmåte for behandling av dysfunksjon
DK0831835T3 (da) Behandling af anorexia
HK1010095A1 (en) Use of 8,9-dehydroestrone for the manufacture of amedicament for the treatment of diseases caused byfree radicals.
ES1034986Y (es) Aparato para el tratamiento del cuerpo humano.
BR0008791A (pt) Derivados anticonvulsivos, úteis no tratamento de tremor essencial
NO984196D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO984198L (no) FremgangsmÕte for behandling av aggresjon
EP0872239A3 (de) Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
RU95119984A (ru) Способ лечения тяжелой сочетанной травмы
ES1030216Y (es) Cinturon terapeutico para el tratamiento de la impotencia.
AU1278700A (en) Novel therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
ES1028926Y (es) Calzador de calcetines para personas impedidas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties